Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis Fungoides

JAMA Dermatol. 2022 Aug 1;158(8):954-956. doi: 10.1001/jamadermatol.2022.2100.

Abstract

This cohort study of data from 39 patients assesses whether the presence of a dominant T-cell receptor clone in peripheral blood is associated with time to systemic treatment in patients with stage IB mycosis fungoides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Clone Cells
  • Humans
  • Mycosis Fungoides* / drug therapy
  • Skin Neoplasms* / drug therapy
  • T-Lymphocytes